Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Coca-Cola HBC is the world’s third-largest anchor bottler for The Coca-Cola Company, operating in 28–29 markets across three continents. It bottles and sells beverages from The Coca-Cola Company and partners with other beverage brands such as Monster Energy, Edrington, Brown‑Forman, Bacardi, Campari, and more. The company is recognized as a global leader in sustainability within the beverage industry and has annual revenues exceeding €7 billion. It serves over 600 million people with a diverse portfolio of more than 100 brands across sparkling drinks, juices, water, sports drinks, energy drinks, tea/coffee products, plant-based beverages, premium spirits and snacks[3][4][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Coca-Cola HBC.